The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gollob Jared since 2021.
This trader's CIK number is 1821198.
At the time of last reporting, Gollob Jared was the Chief Medical Officer of Kymera Therapeutics, Inc.. (stock ticker symbol KYMR).
Also see all insider trading activities at Kymera Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KYMR | 0 | $0 | 5,740 | $176,022 | 0 | $0 |
| 2024 | KYMR | 0 | $0 | 89,081 | $3,594,667 | 85,737 | $178,331 |
| 2023 | KYMR | 0 | $0 | 1,298 | $40,415 | 0 | $0 |
| 2022 | KYMR | 0 | $0 | 0 | $0 | 20,000 | $33,900 |
| 2021 | KYMR | 0 | $0 | 132,493 | $7,656,196 | 49,603 | $85,999 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | KYMR | Sale | 5,740 | 30.67 | 176,022 |
| 2024-07-15 | KYMR | Option Ex | 16,455 | 2.08 | 34,226 |
| 2024-07-16 | KYMR | Option Ex | 23,145 | 2.08 | 48,141 |
| 2024-07-15 | KYMR | Sale | 16,455 | 45.15 | 742,926 |
| 2024-07-16 | KYMR | Sale | 23,145 | 45.84 | 1,061,082 |
| 2024-03-04 | KYMR | Sale | 3,344 | 42.35 | 141,631 |
| 2024-02-09 | KYMR | Sale | 46,137 | 35.74 | 1,649,028 |
| 2024-02-09 | KYMR | Option Ex | 46,137 | 2.08 | 95,964 |
| 2023-03-02 | KYMR | Sale | 1,298 | 31.14 | 40,415 |
| 2022-05-04 | KYMR | Option Ex | 20,000 | 1.70 | 33,900 |
| 2021-11-01 | KYMR | Sale | 42,497 | 61.85 | 2,628,524 |
| 2021-11-02 | KYMR | Sale | 14,996 | 63.58 | 953,385 |
| 2021-11-01 | KYMR | Option Ex | 24,607 | 1.70 | 41,708 |
| 2021-11-02 | KYMR | Option Ex | 14,996 | 2.08 | 31,191 |
| 2021-03-15 | KYMR | Option Ex | 7,800 | 1.31 | 10,218 |
| 2021-03-15 | KYMR | Sale | 10,305 | 60.17 | 620,051 |
| 2021-03-11 | KYMR | Option Ex | 2,200 | 1.31 | 2,882 |
| 2021-03-11 | KYMR | Sale | 4,695 | 60.05 | 281,939 |
| 2021-02-24 | KYMR | Sale | 8,675 | 50.91 | 441,670 |
| 2021-02-23 | KYMR | Sale | 19,285 | 49.65 | 957,558 |
| 2021-02-22 | KYMR | Sale | 9,104 | 52.63 | 479,134 |
| 2021-02-17 | KYMR | Sale | 7,550 | 58.39 | 440,836 |
| 2021-02-18 | KYMR | Sale | 6,499 | 55.94 | 363,541 |
| 2021-02-19 | KYMR | Sale | 8,887 | 55.09 | 489,558 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gollob Jared (Chief Medical Officer of Kymera Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.